Small intestinal transit, absorption, and permeability in patients with AIDS with and without diarrhoea

BACKGROUND Diarrhoea in AIDS is associated with anorexia and weight loss. The importance of gastrointestinal transit in such symptoms has not been addressed. AIMS To assess jejunal to caecal transit times in subjects with AIDS related diarrhoea and weight loss and correlate these with measures of absorptive capacity and intestinal permeability. METHODS Jejunal to caecal transit times were assessed in 20 seronegative controls and 60 HIV seropositive subjects from serum analysis of 3-O-methyl-d-glucose and sulphapyridine after ingestion of the monosaccharide and sulphasalazine in aqueous solution. The method also allows an estimation of gastric emptying times for liquids. Intestinal absorptive capacity and permeability were assessed by a combined test using 3-O-methyl-d-glucose, d-xylose,l-rhamnose, and lactulose. RESULTS Gastric emptying was significantly delayed in all groups of patients with AIDS. Mean jejunal to caecal transit times were not significantly different between controls (246 (62) minutes) and patients without diarrhoea (AIDS, well: 278 (103) minutes; AIDS, wasting: 236 (68) minutes), cytomegalovirus colitis (289 (83) minutes), pathogen negative diarrhoea (192 (100) minutes), or microsporidiosis (190 (113) minutes), although 30% of patients had values below the control range. Patients with cryptosporidiosis differed significantly from controls (135 (35) minutes, p<0.0001), seven of 10 having rapid transit times. Absorptive capacity was reduced and intestinal permeability significantly increased in AIDS, but did not correlate significantly with transit times. CONCLUSION Small bowel transit is accelerated in many patients with AIDS, particularily in protozoal diarrhoea, but is not the sole explanation for malabsorption of monosaccharides.

[1]  P. Koduri Anemia in human immunodeficiency virus infection: the reticulocyte production index. , 2002, The Journal of infectious diseases.

[2]  B. Gazzard,et al.  The metabolic response to opportunistic infections in AIDS , 1996, AIDS.

[3]  B. Gazzard,et al.  Intestinal inflammation, ileal structure and function in HIV , 1996, AIDS.

[4]  I. Bjarnason,et al.  Assessing the site of increased intestinal permeability in coeliac and inflammatory bowel disease. , 1996, Gut.

[5]  D. Gerding Diagnosis of Clostridium difficile--associated disease: patient selection and test perfection. , 1996, The American journal of medicine.

[6]  B Littenberg,et al.  Clinical prediction rules to optimize cytotoxin testing for Clostridium difficile in hospitalized patients with diarrhea. , 1996, The American journal of medicine.

[7]  S. Finkelstein,et al.  Increased expression of keratinocyte growth factor messenger RNA associated with inflammatory bowel disease. , 1996, Gastroenterology.

[8]  B. Gazzard,et al.  Intestinal absorptive capacity, intestinal permeability and jejunal histology in HIV and their relation to diarrhoea. , 1995, Gut.

[9]  S A Jebb,et al.  Energy expenditure and wasting in human immunodeficiency virus infection. , 1995, The New England journal of medicine.

[10]  B. Gazzard,et al.  The treatment of microsporidial diarrhoea with thalidomide. , 1995, AIDS.

[11]  A. Macpherson,et al.  Intestinal permeability: an overview. , 1995, Gastroenterology.

[12]  D. Thea,et al.  Malnutrition in AIDS. , 1993, The Medical clinics of North America.

[13]  H. Pereira,et al.  Enteric viruses and diarrhea in HIV-infected patients. Enteric Opportunistic Infections Working Group. , 1993, The New England journal of medicine.

[14]  M. Hongo,et al.  Diabetic Gastropathy in Patients with Autonomic Neuropathy , 1993, Diabetic medicine : a journal of the British Diabetic Association.

[15]  John W. Ward,et al.  1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. , 1993, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[16]  D. Ellis,et al.  Electron microscopy of rectal biopsies in HIV‐positive individuals , 1993, The Journal of pathology.

[17]  R. Bryan,et al.  Improved light-microscopical detection of microsporidia spores in stool and duodenal aspirates. The Enteric Opportunistic Infections Working Group. , 1992, The New England journal of medicine.

[18]  G. Spinas,et al.  High frequency of human immunodeficiency virus-associated autonomic neuropathy and more severe involvement in advanced stages of human immunodeficiency virus disease. , 1991, Archives of internal medicine.

[19]  P. Sedgwick,et al.  Autonomic denervation in jejunal mucosa of homosexual men infected with HIV. , 1991, AIDS.

[20]  L. Shargel,et al.  A simple and rapid liquid chromatographic method for the determination of major metabolites of sulfasalazine in biological fluids. , 1989, Journal of pharmaceutical sciences.

[21]  F. Kocka,et al.  Duodenal mucosal T cell subpopulation and bacterial cultures in acquired immune deficiency syndrome. , 1987, The American journal of gastroenterology.

[22]  T. Borody,et al.  Sulfapyridine appearance in plasma after salicylazosulfapyridine , 1986 .

[23]  J. Banatvala,et al.  Intestinal permeability and lactose hydrolysis in human rotaviral gastroenteritis assessed simultaneously by non‐invasive differential sugar permeation , 1986, European journal of clinical investigation.

[24]  D. Wade,et al.  A pharmacological method of measuring mouth caecal transit time in man. , 1979, British journal of clinical pharmacology.

[25]  M. Wheeler,et al.  Quantitative Estimation of Clinically Important Monosaccharides in Plasma by Rapid Thin Layer Chromatography , 1978, Annals of clinical biochemistry.

[26]  M. Peppercorn,et al.  The role of intestinal bacteria in the metabolism of salicylazosulfapyridine. , 1972, The Journal of pharmacology and experimental therapeutics.

[27]  F. Ingelfinger,et al.  Sugar absorption tests, with special reference to 3-0-methyl-d-glucose and d-xylose. , 1962, Annals of internal medicine.

[28]  B. Gazzard,et al.  Faecal tumour necrosis factor-α in individuals with HIV-related diarrhoea , 1996 .

[29]  T. Dawson,et al.  gp120 neurotoxicity in primary cortical cultures. , 1994, Advances in neuroimmunology.

[30]  R. Pounder,et al.  Intestinal permeability and function in patients infected with human immunodeficiency virus. A comparison with coeliac disease. , 1993, Scandinavian journal of gastroenterology.

[31]  A. Macpherson,et al.  Nonsteroidal Anti-Inflammatory Drugs and Inflammatory Bowel Disease , 1993 .

[32]  S. Staszewski,et al.  [Intestinal permeability in patients with acquired immunodeficiency syndrome (AIDS)]. , 1991, Klinische Wochenschrift.

[33]  C. A. Teijgeler [Thin-layer chromatography]. , 1962, Pharmaceutisch weekblad.